About Merrimack Pharmaceuticals

website icon
Website
employees icon
Employees
industry icon
Industry
Pharmaceutical
location icon
Location
Cambridge, MA
description icon
Information
Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, design, and development of therapies for the treatment of diseases in the areas of autoimmunity and cancer. It develops MM-093, a human alpha-fetoprotein for the treatment of patients with rheumatoid arthritis and psoriasis; and MM-121, a human monoclonal antibody and therapeutic to block signaling of the ErbB3 receptor. Merrimack Pharmaceuticals, Inc. was formerly known as Atlantic BioPharmaceuticals, Inc. The company was founded in 1993 and is based in Cambridge, Massachusetts.

Merrimack Pharmaceuticals Alternatives

Industry
Pharmaceutical
Industry
Pharmaceutical
Industry
Pharmaceutical
Industry
Pharmaceutical
Industry
Pharmaceutical
Industry
Pharmaceutical
Industry
Pharmaceutical

Frequently Asked Questions about Merrimack Pharmaceuticals

Who are the decision makers in Merrimack Pharmaceuticals?

The decision makers in Merrimack Pharmaceuticals are Alia Al-beer, Andy Porter, Art Kudla, etc. Click to Find Merrimack Pharmaceuticals decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more